Unknown

Dataset Information

Inhibition of glucose-6-phosphate dehydrogenase sensitizes cisplatin-resistant cells to death.


ABSTRACT: The mechanisms of cisplatin resistance, one of the major limitations of current chemotherapy, has only partially been described. We previously demonstrated that cisplatin-resistant ovarian cancer cells (C13), are characterized by reduced mitochondrial activity and higher glucose-dependency when compared to the cisplatin-sensitive counterpart (2008). In this work we further characterized the role of metabolic transformation in cisplatin resistance. By using transmitochondrial hybrids we show that metabolic reprogramming of cisplatin-resistant cell is not caused by inherent mtDNA mutations. We also found that C13 cells not only present an increased glucose-uptake and consumption, but also exhibit increased expression and enzymatic activity of the Pentose Phosphate pathway (PPP) enzyme Glucos

SUBMITTER: Catanzaro D 

PROVIDER: S-EPMC4745784 | biostudies-literature | 2015 Oct

REPOSITORIES: biostudies-literature